--Mylan NV (MYL) is in advanced talks with Merck KGaA (MRK.XE) to acquire the German company's consumer health business, Reuters says, citing unnamed sources.

--An exact amount for the deal couldn't be established, Reuters reports, but the sources are said to be negotiating a price of between 3.5 billion euros ($4.32 billion) and EUR4 billion.

Full story: https://reut.rs/2IT6r2J

Write to Barcelona editors at barcelonaeditors@dowjones.com

(END) Dow Jones Newswires

April 13, 2018 09:23 ET (13:23 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Mylan NV Charts.
Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Mylan NV Charts.